Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android.
Clinical journal of oncology nursing [journal]
- Prevention of Venous Thromboembolism in Adult Patients With Cancer in the Acute Care Setting. [JOURNAL ARTICLE]
- Clin J Oncol Nurs 2014 Apr 21.:A1-A6.
Adult patients with cancer in the acute care setting face numerous potential complications related to malignancy. Risk for development of venous thromboembolism (VTE) is among the most critical of adverse outcomes for this patient population, ultimately leading to increased morbidity and mortality rates. Nurses must be familiar with the general pathophysiology of VTE and pathophysiology specific to oncology to prevent the occurrence of this complex hematologic process. Knowledge of pharmacologic prevention methods, such as low-dose unfractionated heparin, low-molecular weight heparin, and warfarin, as well as mechanical prophylaxis such as graduated compression stockings and intermittent pneumatic compression devices, is essential to preventing VTE. The ability to develop and implement an educational plan tailored to the specific learning needs of each patient also is a vital skill that must be incorporated into the practice of nurses caring for patients with cancer in the acute care setting to prevent the incidence of VTE in this population.
- Variations in self-reported nausea, vomiting, and well-being during the first 10 days postchemotherapy in women with breast cancer. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):E32-6.
Women with breast cancer undergoing chemotherapy experience nausea and vomiting, both common symptoms affecting quality of life. The aim of the current study was to describe how nausea, vomiting, and well-being vary during the first 10 days after chemotherapy in women with breast cancer. A pilot study with a repeated-measurements design was conducted at a Swedish county hospital where 39 women with breast cancer treated with adjuvant chemotherapy were observed. A structured 10-day diary was used for data collection. Of the 39 women in the study, 33 experienced nausea and 6 also experienced vomiting after chemotherapy. Changes in well-being as a result of nausea or vomiting during any part of the day, as well as distress for other reasons, were reported. Well-being also varied among the individuals. The pattern of change in experienced levels of well-being was not homogeneous, nor did it move in any certain direction. The results of this study show that an individualized treatment approach is required to better meet individual women's needs.
- Developing cancer-related educational content and goals tailored to the comanche nation. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):E26-31.
Cancer-related educational content and goals should be modified to the needs of Native Americans to ensure adherence to healthy lifestyles. The current article describes the development of cancer-related educational modules that include creating behavioral goals specific to the people of the Comanche Nation. A community-based participatory research approach was used to conduct focus groups in the Comanche Nation and obtain feedback related to cancer-related educational modules and behavioral goals. Content analysis, verbatim transcriptions, field notes, and observations were used to analyze data and create five major themes. Comanche people need cancer educational modules and goals tailored to their culture to become engaged and maintain interest, thereby improving the likelihood of increasing cancer-related knowledge. Oncology nurses should respect guidance provided by Comanche community members to adapt cancer-related education materials and processes, as well as goal development, to address cultural concepts. When Comanche community members become knowledgeable and work toward healthy behavioral change, cancer health disparities may decrease.
- Adverse event management strategies. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):E19-25.
Patients with metastatic colorectal cancer (mCRC) frequently experience treatment-related adverse events (AEs), which may lead to nonadherence or discontinuation from their treatment regimen. In the phase 3 CORRECT study, the addition of regorafenib to best supportive care (BSC) significantly increased overall survival and progression-free survival compared with placebo plus BSC in patients with mCRC who had progressed on all approved standard care therapies. Although regorafenib showed an acceptable safety profile, patients experienced treatment-related AEs such as hand-foot skin reaction, hypertension, oral mucositis, diarrhea, fatigue, and liver abnormalities. The goal of this article is to help oncology nurses implement a strategic, proactive approach to AE management in patients mCRC treated with regorafenib. The article reviews the most common AEs associated with regorafenib in patients who participated in the CORRECT study and provides a strategy and practical measures that nurses can apply to AE management. In addition, the article provides direction and guidance for educating patients and their caregivers on recognizing and managing potential side effects of regorafenib.
- Patient empowerment in the management of chronic myeloid leukemia. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):E12-8.
Patient empowerment is a patient-centered approach to care in which healthcare providers nurture patients' innate abilities to self-manage and incorporate patient goals for therapy into the overall management plan. Standard care of chronic myeloid leukemia (CML) requires lifelong medication with oral therapy and regular follow-up. The success of CML treatment, therefore, depends on a high degree of patient involvement and motivation, as well as strong collaboration between patients and healthcare providers. Oncology nurses can support patients with CML from the time of diagnosis to the end of treatment to ensure they maintain high levels of involvement in their care. At the author's center, patients who most actively collaborate with their physicians in treatment decisions take personal responsibility for the quality of their care and show good adherence to treatment. In the current article, the author discusses the potential effect of patient response to cancer diagnosis on clinical outlook and describes strategies in place at the cancer center to ensure that patients diagnosed with CML have the best chance at keeping their cancer under control.
- The knowledge patients impart. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):250.
A tear falls down his left cheek as he recalls times of athleticism and strength. A mind fine tuned with operatic music and best selling novels. He smiles as you grasp his right hand and squeeze it. "How are you Mr. Frankle? Do you have any pain?"
- Transarterial chemoembolization versus no intervention or placebo intervention for liver metastases. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):249-50.
To assess the benefit and harm of transarterial chemoembolization treatment when compared to no intervention or a placebo intervention for patients with liver metastases.
- Care, compassion, and communication in professional nursing: art, science, or both. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):247-8.
Debate continues as to whether nursing is a science, art, or a combination of the two. Given the recent growing emphasis in the current healthcare environment to deliver patient-centered care, the art of nursing and its impact on patient outcomes is being re-examined. The current article discusses a case narrative to provide a venue for self-reflection in nursing practice.
- Aspergillus pneumonia in adult patients with acute leukemia. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):243-6.
Aspergillus pneumonia often is a fatal consequence of prolonged neutropenia in patients with acute leukemia. Despite prompt diagnosis and adequate antifungal therapy, mortality remains high among these patients. Recognizing early signs and symptoms, as well as risk factors, is the key to reducing morbidity and mortality.
- Reevaluating the neutropenic diet: time to change. [Journal Article]
- Clin J Oncol Nurs 2014 Apr 1; 18(2):239-41.
The neutropenic diet historically has been a mainstay in oncology practice, with many providers continuing to adhere tightly to the diet for patients with neutropenia. However, clinically sound evidence remains limited and weak and does not support the diet as a foundation for policy and practice. Therefore, two questions remain: Does evidence exist to support the effectiveness of the neutropenic diet in reducing infection rates in the neutropenic oncology population? Based on limited evidence supporting the neutropenic diet in this population, what clinically sound diet strategies are best for these patients?